Germline Variation Predicts Treatment Response in Multiple Myeloma

被引：0

作者：

Roter, Kyle ^{[1
]}

Hu, Donglei ^{[1
]}

Clay-Gilmour, Alyssa ^{[2
]}

Huntsman, Scott ^{[1
]}

Shah, Nina D. ^{[1
]}

Wong, Sandy W. ^{[1
]}

Martin, Thomas G., III ^{[1
]}

Wolf, Jeffrey Lee ^{[1
]}

Binder, Moritz ^{[3
]}

Kumar, Shaji K. ^{[4
]}

Rajkumar, S. Vincent ^{[3
]}

Slager, Susan L. ^{[4
]}

Vachon, Celine M. ^{[5
]}

Ziv, Elad ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

[2] Univ South Carolina, Columbia, SC 29208 USA

[3] Mayo Clin, Div Hematol, Rochester, MN USA

[4] Mayo Clin, Rochester, MN USA

[5] Mayo Clin, Div Epidemiol, Rochester, MN USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-129344

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4397

引用

页数：3

共 50 条

[1] Tumor Specific cfDNA Predicts Treatment Response of Multiple Myeloma Patients
Vrabel, David
Gregorova, Jana
Sedlarikova, Lenka
Almasi, Martina
Bezdekova, Renata
Stork, Martin
Krejci, Marta
Adam, Zdenek
Pour, Ludek
Hajek, Roman
Sevcikova, Sabina
BLOOD, 2018, 132
[2] Germline predisposition in multiple myeloma
Rodrigues, Fernanda Martins
Jasielec, Jagoda
Perpich, Melody
Kim, Aelin
Moma, Luke
Li, Yize
Storrs, Erik
Wendl, Michael C.
Jayasinghe, Reyka G.
Fiala, Mark
Stefka, Andrew
Derman, Benjamin
Jakubowiak, Andrzej J.
DiPersio, John F.
Vij, Ravi
Godley, Lucy A.
Ding, Li
ISCIENCE, 2025, 28 (01)
[3] Variation in the Treatment of Multiple Myeloma in the Real World
Chhun, Leena
Zheng, Cheng
Piboonvaranggoon, Jayne
Mallick, Elora
Wren, Jennifer
Nam, Grace
Barquilla, Ricardo Lopez
Dardac, Alexandra
Blau, Sibel
Senecal, Francis M.
Namburi, Swathi
Cowan, Andrew J.
Bensinger, William I.
Kumar, Shaji K.
Richardson, Paul G.
Anderson, Kenneth
Blau, C. Anthony
BLOOD, 2020, 136
[4] Circulating tumour DNA-based molecular response predicts treatment outcome in multiple myeloma
Mithraprabhu, Sridurga
Khong, Tiffany
Yuen, Flora
Reynolds, John
Durie, Brian
Spencer, Andrew
CANCER RESEARCH, 2023, 83 (07)
[5] A Multidisciplinary Model Predicts Clinical Response in Relapsed Multiple Myeloma
Shain, Kenneth H.
Silva, Ariosto
Meads, Mark B.
Distler, Allison
Jacobson, Timothy
Gatenby, Robert
Baz, Rachid
Silva, Maria
Rebatchouk, Dmitri
Cubitt, Chris
BLOOD, 2015, 126 (23)
[6] A Role for Germline Variants in Multiple Myeloma?
Walker, Brian A.
BLOOD CANCER DISCOVERY, 2024, 5 (06): : 375 - 376
[7] Pathogenic Germline Variants in Multiple Myeloma
Thibaud, Santiago
Etra, Aaron
Subaran, Ryan
Soens, Zachry
Newman, Scott
Chen, Rong
Chari, Ajai
Cho, Hearn Jay
Jagannath, Sundar
Madduri, Deepu
Melnekoff, David T.
Richard, Shambavi
Richter, Joshua
Sanchez, Larysa
Huang, Kuan-lin
Lagana, Alessandro
Parekh, Samir
Onel, Kenan
BLOOD, 2021, 138
[8] Characterization of Germline Variants in Multiple Myeloma
Rodrigues, Fernanda Martins
Gao, Qingsong
Huang, Kuan-lin
Scott, Adam David
Foltz, Steven M.
King, Justin
Fiala, Mark A.
Kohnen, Daniel R.
DiPersio, John F.
Vij, Ravi
Ding, Li
BLOOD, 2018, 132
[9] Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple Myeloma
Rodriguez-Garcia, Alba
Arroyo, Andres
Garcia-Vicente, Roberto
Morales, Maria Luz
Gomez-Gordo, Ruben
Justo, Pablo
Cuellar, Clara
Sanchez-Pina, Jose
Lopez, Nieves
Alonso, Rafael
Puig, Noemi
Mateos, Maria-Victoria
Ayala, Rosa
Gomez-Garre, Dulcenombre
Martinez-Lopez, Joaquin
Linares, Maria
CLINICAL CANCER RESEARCH, 2024, 30 (04) : 904 - 917
[10] Germline genetic variation and treatment response on CCG-1891
Sepe, Dana M.
McWilliams, Thomas
Chen, Jinbo
Kershenbaum, Aaron
Zhao, Huaqing
La, Mei
Devidas, Meenakshi
Lange, Beverly
Rebbeck, Timothy R.
Aplenc, Richard
PEDIATRIC BLOOD & CANCER, 2012, 58 (05) : 695 - 700

← 1 2 3 4 5 →